Nan Fung Trinity
PVLA icon

Nan Fung Trinity’s Palvella Therapeutics PVLA Stock Holding History

Nan Fung Trinity’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.26M Buy
+52,630
New +$7.8M 0.7% 47

Other funds holding PVLA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

Nan Fung Trinity's PVLA Position: Q3 2026 in Review

Nan Fung Trinity opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 52,630 shares worth $7.26M. The stake represents 0.7% of the portfolio and ranks #47 among its holdings.

141 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • Nan Fung Trinity held 52,630 shares of Palvella Therapeutics worth $7.26M as of Q3 2026.
  • Palvella Therapeutics was a new Nan Fung Trinity position in Q3 2026.
  • Palvella Therapeutics made up 0.7% of Nan Fung Trinity's portfolio in Q3 2026, its #47 holding.
  • 141 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on Nan Fung Trinity's 13F filing for Q3 2026, filed 6 Nov 2026.